AQP4 and neuromyelitis optica: CD19+CD27highCD38highCD130− plasmablasts are increased in peripheral blood of NMO patients, which secrete AQP4-IgG under stimulation by IL-6 (9), and anti-CD20 monoclonal antibody (rituximab) is effective in some NMOSD patients (10).